1,061
Views
2
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Review

Available evidence and potential for vaccines for reduction in antibiotic prescriptions

ORCID Icon
Article: 2151291 | Received 25 Oct 2022, Accepted 20 Nov 2022, Published online: 05 Dec 2022

References

  • WHO. Antimicrobial resistance. Fact sheets. 2021 Nov 17. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
  • WHO. WHO strategic priorities on antimicrobial resistance. Preserving antimicrobials for today and tomorrow. WHO; 2021. https://apps.who.int/iris/bitstream/handle/10665/351719/9789240041387-eng.pdf?sequence=1&isAllowed=y.
  • Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–8. doi:10.1016/S0140-6736(21)02724-0.
  • OECD. Stemming the superbug tide: just a few dollars more. In: OECD health policy studies. Paris: OECD Publishing; 2018. doi:10.1787/9789264307599-en.
  • Tagliabue A, Rappuoli R. Changing priorities in vaccinology: antibiotic resistance moving to the top. Front Immunol. 2018;9:1068. doi:10.3389/fimmu.2018.01068.
  • Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi:10.1016/S1473-3099(18)30605-4.
  • European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2020. Stockholm: ECDC; 2022. https://www.ecdc.europa.eu/sites/default/files/documents/AER-EARS-Net-2020.pdf.
  • ECDC. Antibiotic resistance: how does antibiotic resistance spread? Infographic. [accessed 2014 Nov 18]. https://www.ecdc.europa.eu/en/publications-data/antibiotic-resistance-how-does-antibiotic-resistance-spread.
  • WHO. Quadripartite Memorandum of Understanding (MoU) signed for a new era of One Health collaboration. 2022 Apr 22. https://www.who.int/news/item/29-04-2022-quadripartite-memorandum-of-understanding-mou-signed-for-a-new-era-of-one-health-collaboration.
  • European Commission. Communication from the Commission to the Council and the European Parliament “A European One Health Action Plan against antimicrobial resistance (AMR)”. 2017 Jun 29. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52017DC0339&from=IT.
  • Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Lucaroni F, Camoni L, Barbieri MM, Ricciardi W, Stefanelli P, Rezza G. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015. Vaccine. 2018;36(11):1435–43. doi:10.1016/j.vaccine.2018.01.065.
  • WHO. Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: an action framework. World Health; 2020.
  • Alghamdi S. The role of vaccines in combating antimicrobial resistance (AMR) bacteria. Saudi J Biol Sci. 2021;28(12):7505–10. doi:10.1016/j.sjbs.2021.08.054.
  • Malarski M, Hasso-Agopsowicz M, Soble A, Mok W, Mathewson S, Vekemans J. Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance’s 2018 vaccine investment strategy: report from an expert survey. F1000Res. 2019;8:1685. doi:10.12688/f1000research.20100.1.
  • Jansen KU, Anderson AS. The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother. 2018;14(9):2142–49. doi:10.1080/21645515.2018.1476814.
  • Jit M, Cooper B. The role of vaccines in combating antimicrobial resistance. In: North J, Anderson M, Cecchini M, and Mossialos E, editors. Challenges to tackling antimicrobial resistance: economic and policy responses (European Observatory on Health Systems and Policies). Cambridge: Cambridge University Press; 2020. p. 181–206. doi:10.1017/9781108864121.009.
  • Andrejko K, Ratnasiri B, Hausdorff WP, Laxminarayan R, Lewnard JA. Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis. Lancet Microbe. 2021;2(9):e450–60. PMID: 34485957; PMCID: PMC8410609. doi:10.1016/S2666-5247(21)00064-1.
  • Micoli F, Bagnoli F, Rappuoli R, Serruto D. The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol. 2021;19(5):287–302. doi:10.1038/s41579-020-00506-3.
  • Oliver SE. Chapter 2: Haemophilus influenzae invasive disease. In: VPD Surveillance Manual. [ accessed 2019 Oct 25]. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt02-hib.html.
  • Slack M, Esposito S, Haas H, Mihalyi A, Nissen M, Mukherjee P, Harrington L. Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication. Expert Rev Vaccines. 2020;19(10):903–17. doi:10.1080/14760584.2020.1825948.
  • Heliodoro CIM, Bettencourt CR, Bajanca-Lavado MP, Portuguese Group for the Study of Haemophilus influenzae invasive infection. Molecular epidemiology of invasive Haemophilus influenzae disease in Portugal: an update of the post-vaccine period, 2011–2018. Eur J Clin Microbiol Infect Dis. 2020;39(8):1471–80. doi:10.1007/s10096-020-03865-0.
  • McElligott M, Meyler K, Bennett D, Mulhall R, Drew RJ, Cunney R. Epidemiology of Haemophilus influenzae in the Republic of Ireland, 2010–2018. Eur J Clin Microbiol Infect Dis. 2020;39(12):2335–44. doi:10.1007/s10096-020-03971-z.
  • Wen S, Feng D, Chen D, Yang L, Xu Z. Molecular epidemiology and evolution of Haemophilus influenzae. Infect Genet Evol. 2020;80:104205. doi:10.1016/j.meegid.2020.104205.
  • Gierke R, McGee L, Beall B, Pilishvili T. Chapter 11: pneumococcal. In: VPD surveillance manual. [accessed 2020 Jun 29]. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt11-pneumo.html.
  • Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen JA, Klugman K, Davies S. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(10014):168–75. doi:10.1016/S0140-6736(15)00474-2.
  • Lu EY, Chen HH, Zhao H, Ozawa S. Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China. Proc Natl Acad Sci USA. 2021;118(13):e2004933118. doi:10.1073/pnas.2004933118.
  • Blasi F, Bonanni P, Braido F, Gabutti G, Marchetti F, Centanni S. The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context. Hum Vaccin Immunother. 2020;16(2):340–48. doi:10.1080/21645515.2019.1652517.
  • Lee GM, Lett S, Schauer S, LeBaron C, Murphy TV, Rusinak D, Lieu TA, Massachusetts Pertussis Study Group. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis. 2004;39(11):1572–80. doi:10.1086/425006.
  • Moore A, Harnden A, Grant CC, Patel S, Irwin RS, Altman KW, Azoulay E, Barker AF, Bolser DC, Birring SS, CHEST Expert Cough Panel. Clinically diagnosing pertussis-associated cough in adults and children: CHEST Guideline and Expert Panel Report. Chest. 2019;155(1):147–54. doi:10.1016/j.chest.2018.09.027.
  • Centers for Disease Control and Prevention (CDC). Diagnosis confirmation. 2019. [ accesso 2022 Gennaio]. https://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosis-confirmation.html.
  • Kinkade S, Long NA. Acute bronchitis. Am Fam Physician. 2016;94(7):560–65. PMID: 27929206.
  • Centers for Disease Control and Prevention (CDC). Cold vs Flu. https://www.cdc.gov/flu/symptoms/coldflu.htm.
  • Bhavsar A, Aris E, Harrington L, Simeone JC, Ramond A, Lambrelli D, Papi A, Boulet LP, Meszaros K, Jamet N, et al. Burden of pertussis in individuals with a diagnosis of asthma: a retrospective database study in England. J Asthma Allergy. 2022;15:35–51. doi:10.2147/JAA.S335960.
  • Marchetti F, Prato R, Viale P. Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance. Human Vaccin Immunother. 2021;17(11):4283–90. doi:10.1080/21645515.2021.1969853.
  • Buchy P, Ascioglu S, Buisson Y, Datta S, Nissen M, Tambyah PA, Vong S. Impact of vaccines on antimicrobial resistance. Int J Infect Dis. 2020;90:188–96. doi:10.1016/j.ijid.2019.10.005.
  • Klugman KP, Black S. Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects. Proc Natl Acad Sci USA. 2018;115(51):12896–901. doi:10.1073/pnas.1721095115.
  • Giacchetta I, Primieri C, Cavalieri R, Domnich A, de Waure C. The burden of seasonal influenza in Italy: a systematic review of influenza-related complications, hospitalizations, and mortality. Influenza Other Respir Viruses. 2022;16(2):351–65. doi:10.1111/irv.12925.
  • Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB, Atmar RL. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 influenza season. MMWR Recomm Rep. 2020;69(8):1–24. doi:10.15585/mmwr.rr6908a1.
  • Kwong JC, Maaten S, Upshur RE, Patrick DM, Marra F. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis. 2009;49(5):750–56. doi:10.1086/605087.
  • Piltcher OB, Kosugi EM, Sakano E, Mion O, Testa JRG, Romano FR, Santos MCJ, Di Francesco RC, Mitre EI, Bezerra TFP, et al. How to avoid the inappropriate use of antibiotics in upper respiratory tract infections? A position statement from an expert panel. Braz J Otorhinolaryngol. 2018;84(3):265–79. doi:10.1016/j.bjorl.2018.02.001.
  • Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, et al. Burden of medically attended influenza infection and cases averted by vaccination – United States, 2013/14 through 2015/16 influenza seasons. Vaccine. 2018;36(4):467–72. doi:10.1016/j.vaccine.2017.12.014.
  • Klein EY, Schueller E, Tseng KK, Morgan DJ, Laxminarayan R, Nandi A. The impact of influenza vaccination on antibiotic use in the United States, 2010-2017. Open Forum Infect Dis. 2020;7(7):ofaa223. PMID: 32665959; PMCID: PMC7336555. doi:10.1093/ofid/ofaa223.
  • Knight GM, Clarkson M, de Silva TI. Potential impact of influenza vaccine roll-out on antibiotic use in Africa. J Antimicrob Chemother. 2018;73(8):2197–200. doi:10.1093/jac/dky172.
  • Esposito S, Principi N, European Society of Clinical Microbiology Infectious Diseases (ESCMID) Vaccine Study Group (EVASG). Influenza vaccination and prevention of antimicrobial resistance. Expert Rev Vaccines. 2018;17(10):881–88. doi:10.1080/14760584.2018.1525298.
  • Muller-Pebody B, Sinnathamby MA, Warburton F, Rooney G, Andrews N, Whitaker H, Henderson KL, Tsang C, Hopkins S, Pebody RG. Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England. Vaccine. 2021;39(45):6622–27. doi:10.1016/j.vaccine.2021.09.069.
  • Barchitta M, Maugeri A, Vinci R, Agodi A. The inverse relationship between influenza vaccination and antimicrobial resistance: an ecological analysis of Italian data. Vaccines (Basel). 2022;10(4):554. doi:10.3390/vaccines10040554.
  • Yin M, Huang L, Zhang Y, Yu N, Xu X, Liang Y, Ni J. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Rev Vaccines. 2018;17(7):653–63. doi:10.1080/14760584.2018.1495077.
  • Vandenhaute J, Tsakeu E, Chevalier P, Pawaskar M, Benčina G, Vertriest J. Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis. BMC Infect Dis. 2021;21(1):1150. doi:10.1186/s12879-021-06848-4.
  • Pawaskar M, Fergie J, Harley C, Samant S, Veeranki P, Diaz O, Conway JH. Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States. PLoS One. 2022;17(6):e0269916. doi:10.1371/journal.pone.0269916.
  • Hall EW, Tippett A, Fridkin S, Anderson EJ, Lopman B, Benkeser D, Baker JM. Association between rotavirus vaccination and antibiotic prescribing among commercially insured US children, 2007-2018. Open Forum Infect Dis. 2022;9(7):ofac276. doi:10.1093/ofid/ofac276.
  • Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD. Current and new rotavirus vaccines. Curr Opin Infect Dis. 2019 Oct;32(5):435–44. doi:10.1097/QCO.0000000000000572.
  • CDC. Rotavirus. https://www.cdc.gov/rotavirus/index.html.
  • Nam HH, Ison MG. Respiratory syncytial virus. Semin Respir Crit Care Med. 2021;42(6):788–99. Epub 2021 Dec 16. PMID: 34918321. doi:10.1055/s-0041-1736182.
  • Obolski U, Kassem E, Na’Amnih W, Tannous S, Kagan V, Muhsen K. Unnecessary antibiotic treatment of children hospitalised with respiratory syncytial virus (RSV) bronchiolitis: risk factors and prescription patterns. J Glob Antimicrob Resist. 2021;27:303–08. doi:10.1016/j.jgar.2021.10.015.
  • Fitzpatrick T, Malcolm W, McMenamin J, Reynolds A, Guttmann A, Hardelid P. Community-based antibiotic prescribing attributable to Respiratory Syncytial Virus and other common respiratory viruses in young children: a population-based time-series study of Scottish children. Clin Infect Dis. 2021;72(12):2144–53. doi:10.1093/cid/ciaa403.
  • Hartnett J, Donga P, Ispas G, Vandendijck Y, Anderson D, House S, Suner S. Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the hospitalized acute respiratory tract infection study. Influenza Other Respir Viruses. 2022;16(5):906–15. doi:10.1111/irv.12994.
  • Walsh E, Lee N, Sander I, Stolper R, Zakar J, Wyffels V, Myers D, Fleischhackl R. RSV-associated hospitalization in adults in the USA: a retrospective chart review investigating burden, management strategies, and outcomes. Health Sci Rep. 2022;5(3):e556. doi:10.1002/hsr2.556.
  • Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE Jr, Cutland CL, Eckert L, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2022;S1473-3099(22):00291–2. doi:10.1016/S1473-3099(22)00291-2.
  • Jansen KU, Gruber WC, Simon R, Wassil J, Anderson AS. The impact of human vaccines on bacterial antimicrobial resistance. A review. Environ Chem Lett. 2021;19(6):4031–62. doi:10.1007/s10311-021-01274-z.
  • Doherty TM, Hausdorff WP, Kristinsson KG. Effect of vaccination on the use of antimicrobial agents: a systematic literature review. Ann Med. 2020;52(6):283–99. Epub 2020 Jun 29. PMID: 32597236; PMCID: PMC7880080. doi:10.1080/07853890.2020.1782460. .
  • WHO. Global action plan on antimicrobial resistance. 2015. https://www.who.int/publications/i/item/9789241509763.